The global pyrogen testing market reached a value of US$ 1.10 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 2.04 Billion by 2027, exhibiting at a CAGR of 10.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Pyrogen testing is conducted to detect both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in ensuring the safety of the parenteral pharmaceutical product and medical device and avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some of the commonly utilized methods of pyrogen testing include limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). At present, its demand is escalating across the globe as it is robust, sensitive, and scalable.
The flourishing pharmaceutical and biotechnology industries around the world represent one of the key factors bolstering the growth of the market. Pyrogen testing finds extensive applications in these industries for the safe development and release of infection-free products at a cost-effective price. It is also utilized for determining microbes or the presence of metabolites in drugs during the manufacturing process. Moreover, the testing aids in improving the management of infectious diseases by determining the disease severity, recovery, and sequelae. As a result, it is employed in the production of coronavirus disease (COVID-19) vaccines worldwide. This, along with the increasing prevalence of chronic ailments, such as heart diseases, cancer, and diabetes, is positively influencing the market. Furthermore, leading players are introducing technologically advanced and cost-effective pyrogen testing techniques that provide a more relevant prediction of pyrogenic activity compared to the traditional methods, which is creating a favorable market outlook. Besides this, the launch of the new therapeutics and continuous funding of research and development (R&D) activities by manufacturing companies and governing agencies of numerous countries is acting as another major growth-inducing factor.
The publisher provides an analysis of the key trends in each sub-segment of the global pyrogen testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type and application.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.
Pyrogen testing is conducted to detect both endotoxin and non-endotoxin pyrogenic contaminants in aqueous parenteral. It assists in ensuring the safety of the parenteral pharmaceutical product and medical device and avoiding life-threatening diseases and fatal endotoxic shock induced by pyrogenic substances. Some of the commonly utilized methods of pyrogen testing include limulus amebocyte lysate (LAL) test, recombinant factor C (rFC) test, rabbit pyrogen test (RPT), and monocyte activation test (MAT). At present, its demand is escalating across the globe as it is robust, sensitive, and scalable.
Pyrogen Testing Market Trends:
The flourishing pharmaceutical and biotechnology industries around the world represent one of the key factors bolstering the growth of the market. Pyrogen testing finds extensive applications in these industries for the safe development and release of infection-free products at a cost-effective price. It is also utilized for determining microbes or the presence of metabolites in drugs during the manufacturing process. Moreover, the testing aids in improving the management of infectious diseases by determining the disease severity, recovery, and sequelae. As a result, it is employed in the production of coronavirus disease (COVID-19) vaccines worldwide. This, along with the increasing prevalence of chronic ailments, such as heart diseases, cancer, and diabetes, is positively influencing the market. Furthermore, leading players are introducing technologically advanced and cost-effective pyrogen testing techniques that provide a more relevant prediction of pyrogenic activity compared to the traditional methods, which is creating a favorable market outlook. Besides this, the launch of the new therapeutics and continuous funding of research and development (R&D) activities by manufacturing companies and governing agencies of numerous countries is acting as another major growth-inducing factor.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global pyrogen testing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type and application.
Breakup by Product:
- Instruments
- Kits and Reagents
- Services
Breakup by Test Type:
- In-vitro Tests
- LAL Tests
- Rabbit Tests
- Others
Breakup by Application:
- Pharmaceutical and Biologics
- Medical Devices
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.
Key Questions Answered in This Report:
- How has the global pyrogen testing market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pyrogen testing market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pyrogen testing market and who are the key players?
- What is the degree of competition in the industry?
Frequently Asked Questions about the Global Pyrogen Testing Market
What is the estimated value of the Global Pyrogen Testing Market?
What is the growth rate of the Global Pyrogen Testing Market?
What is the forecasted size of the Global Pyrogen Testing Market?
Who are the key companies in the Global Pyrogen Testing Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 143 |
| Published | March 2022 |
| Forecast Period | 2021 - 2027 |
| Estimated Market Value ( USD | $ 1.1 Billion |
| Forecasted Market Value ( USD | $ 2.04 Billion |
| Compound Annual Growth Rate | 10.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Pyrogen Testing Market
6 Market Breakup by Product
7 Market Breakup by Test Type
8 Market Breakup by Application
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Charles River Laboratories International Inc.
- Ellab A/S
- Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
- Lonza Group AG
- Merck KGaA
- Microcoat Biotechnologie GmbH
- Nelson Laboratories LLC (Sotera Health)
- North American Science Associates Inc.
- Pacific Biolabs Inc.
- Sanquin
- Thermo Fisher Scientific Inc
- Toxikon Corporation
- Wuxi Apptec.
Methodology
LOADING...
